Ignite Creation Date:
2025-12-25 @ 1:18 AM
Ignite Modification Date:
2026-01-03 @ 10:57 AM
Study NCT ID:
NCT00334893
Status:
COMPLETED
Last Update Posted:
2017-11-29
First Post:
2006-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Sponsor:
Organization: